Sign Out
In clinical studies, administration of ezetimibe, 50 mg/day to 15 healthy subjects for up to 14 days, 40 mg/day to 18 patients with primary hyperlipidemia for up to 56 days was generally well tolerated.
In the event of an overdose, symptomatic and supportive measures should be employed.
Continue with Google